Patent Protection of the Traditional Chinese Medicine and Its Impact on the Related Industries in China
Abstract
Traditional Chinese Medicine (TCM) IP strategy is an integral part of China's national IP strategy. It is of great value for the implementation of the Strategy to study the status quo of the patent protection of TCM and its impact on the related industries. This paper gives a multidimensional illustration of the current of the patent protection of TCM in China in view of the following aspects: patent applications, patent grants, PCT and the object of the patent protection of TCM. It demonstrates the impact of patent protection on the TCM industry after a detailed analysis of the R&D expense, social effects, human resources in TCM institutions and their output of scientific/technical papers. Finally, it analyzes the challenges facing the patent protection of TCM and discusses some tentative solutions.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Increased focus on scientific research and development has led to a noteworthy increase in Chinese medicine-based drug patents within China, growing steadily from 43 in 1985 to 629 in 1992, and rising sharply to 2,166 in 2000.
“Increased focus on scientific research and development has certainly led to a noteworthy increase in Chinese medicine-based drug patents within China, growing steadily from 43 in 1985 to 629 in 1992, and rising sharply to 2,166 in 2000.”
From Indian Imaginaries of Chinese Success in the Global Herbal Medicine Market (2019) · cites this paper as Qiao and Zhu 2009, 47
China holds only a 3-5 percent share of the global processed herbal medicine/supplement market (outside China), while Japan and Korea together hold 80-90 percent.
“China holds only a 3-5 percent share of the global processed herbal medicine/supplement market (outside China), while Japan and Korea together hold 80-90 percent.”
From Indian Imaginaries of Chinese Success in the Global Herbal Medicine Market (2019) · cites this paper as Qiao and Zhu 2009, 54
Only four of the 68 patents on the Chinese medicine herb ginkgo are owned by foreigners, but they cover almost all the ginkgo extraction processes.
“Although only four of the 68 patents on the Chinese medicine herb ginkgo are owned by foreigners, they cover almost all the ginkgo extraction processes.”
From Indian Imaginaries of Chinese Success in the Global Herbal Medicine Market (2019) · cites this paper as Qiao and Zhu 2009, 47
Cited by
Sorted by citations
Indian Imaginaries of Chinese Success in the Global Herbal Medicine Market
Kudlu, C., & Nichter, M. (2019) · Asian Medicine · doi:10.1163/15734218-12341437 · Cited by 7 · see citing works
- Authors
- Yongzhong, Q., & Xuezhong, Z.
- Affiliations
- Huazhong University of Science and Technology (CN)
- Venue
- Journal of International Biotechnology Law
- Publisher
- Walter de Gruyter GmbH
- Published
- 2009-01
- Volume
- 6
- Issue
- 3
- ISSN
- 1612-6068 (ISSN-L)
- OpenAlex
- W2080131198
- Cited by
- 3
- References
- 0
- Citations by year
- 2026: 1 · 2021: 1 · 2019: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of International Biotechnology Law (publishedVersion)
- Funders
- National Natural Science Foundation of China
- National Social Science Fund of China
- Topics
- Social Sciences › Business, Management and Accounting › Management of Technology and Innovation › Intellectual Property and Patents
- Social Sciences › Law › Intellectual Property Law
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Keywords
- traditional Chinese medicine, patent protection, intellectual property strategy, patent applications, patent grants, R&D investment, scientific and technical publications, China
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
